Napredna pretraga

Pregled bibliografske jedinice broj: 463942

Systemic thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke: first Croatian experiences


Matijević, Vesna; Alvir, Domagoj; Malojčić, Branko; Unušić, Lea; Šupe, Svjetlana; Boban, Marina; Bujan-Kovač, Andreja; Habek, Mario; Poljaković, Zdravka
Systemic thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke: first Croatian experiences // Neurological sciences, 31 (2010), 6; 693-697 doi:10.1007/s10072-010-0237-1 (međunarodna recenzija, članak, znanstveni)


Naslov
Systemic thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke: first Croatian experiences

Autori
Matijević, Vesna ; Alvir, Domagoj ; Malojčić, Branko ; Unušić, Lea ; Šupe, Svjetlana ; Boban, Marina ; Bujan-Kovač, Andreja ; Habek, Mario ; Poljaković, Zdravka

Izvornik
Neurological sciences (1590-1874) 31 (2010), 6; 693-697

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Stroke; thrombolysis; rt-PA

Sažetak
In September 2003, recombinant tissue plasminogen activator (rt-PA) for acute treatment of ischemic stroke was finally approved by the Croatian Ministry of Health. For the next 5 years, only three stroke units in the country implemented this therapy in their routine practice until summer 2008, when neurological wards in most Croatian hospitals started to treat acute stroke patients with systemic thrombolysis. We present a 2-year experience of thrombolytic therapy (2006-2008) in the stroke unit of the University Hospital in Zagreb, Croatian largest hospital, serving nearly one-fifth of the citizens of Croatia. Obtained data (vitals at admission and before administration of rt-PA ; NIHSS and MRS scores at admission, 2 h and 7th day after rt-PA treatment, "time to door" and "door to needle" intervals, duration of hospital treatment as well as outcomes and complications of our 66 thrombolysed patients) are presented and discussed. We also present our results regarding benefits of this therapy as well as possible reasons for complications noticed.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Projekt / tema
108-1081874-1988 - Molekularne i biološke osnove demijelinizacijskih bolesti živčanog sustava (Vesna Brinar, )

Ustanove
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati